Prostate cancer is a silent disease. There are no outward signs to signal that something is wrong and there’s no guaranteed ...

Removing the fallopian tubes during another gynecological operation was associated with a 78% lower risk of serous ovarian cancer in a large Canadian study. Serous cancer is the most common ovarian ...

I reject the idea that a man who keeps every prostate cancer surveillance appointment has ‘untreated cancer,’” writes Howard ...

Sanoj Punnen, M.D., a urologic oncologist at Sylvester Comprehensive Cancer Center and Vice Chair of Research at Desai Sethi Urology Institute, part of UHealth, the University of Miami Health System, ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

RARE prostate cancer nomograms showed strong performance in predicting one-, three-, and five-year overall survival (OS) and ...

Supporting Emma Symonds in Advancing Prostate Cancer Research / cancer, Emma Symonds, Kirsty Danielson, OncoDaily, Oncology, ...

Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...

Prostate cancer screening generally begins around age 50, while men at higher risk may consider starting earlier, closer to ...

EHS leadership encouraged men to get regular screenings, which the hospital provides periodically throughout the year for ...